Dark Blue Therapeutics
Dark Blue Therapeutics, an oncology focused spin-out from the LAB282 therapeutic accelerator program, is a pre-clinical biotech company tackling cancer with new therapies that target cancer cells' vulnerabilities and dependencies.
Something looks off?Open jobs at Dark Blue Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.